Statin-associated myopathy : from genetic predisposition to clinical management /
Statin-associated myopathy (SAM) represents a broad spectrum of disorders from insignificant myalgia to fatal rhabdomyolysis. Its frequency ranges from 1-5 % in clinical trials to 15-20 % in everyday clinical practice. To a large extent, these variations can be explained by the definition used. Thus...
| Hlavní autor: |
Vrablík, Michal, 1973-
(
Autor )
|
|---|---|
| Další autoři: |
Zlatohlávek, Lukáš, 1978-
(
Autor )
|
| Typ dokumentu: | Článek |
| Jazyk: |
angličtina |
| ISSN: | 0862-8408 |
| Zdroj: | Physiological research: Vol. 63, is. suppl. 3 (2014), s. S327-S334. |
| Předmět: | |
| Externí odkaz: |
|